The Mechanism of Articular Cartilage Degeneration in Osteoarthritis and Rheumatoid Arthritis

骨关节炎和类风湿关节炎的关节软骨退变机制

基本信息

  • 批准号:
    05671236
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

Immunohistochemical and biochemical studies were undertaken in order to investigate the mechanism of articular cartilage degeneration if patients with osteoarthritis and rheumatoid arthritis. Polyclonal antibodies against cyanogen bromide (CB) peptide of Type II colagen that specifically react with unwound alpha-chains and CB-derived peptides of human Type II collagen were utilized to identify degradation of Type II collagen fibers in articular cartilage. In the case of human osteoarthritic cartilage with mild degeneration, the most prominent staining by the anti-CB peptide antibodies was found in the superficial fibrillation and in the interterritorial matrix of the superficial and mid-zones. Incontrast, these regions showed weak staining by both anti-Type II collagen antibodies and anti-proteoglycan antibodies. Moreover, Staining by anti-fibronectin antibodies and anti-dermatan sulfate proteoglycan antibodies was observed around cell clusters in the superficial zone. On the other hand, in the case of rheumatoid arthritis, deep zone of the articular cartilage was well stained by the anti-CB peptide antibodies.Synthesis of the Type II collagen and proteoglycans was also investigated using cultured human chondrocytes obtained from osteoarthritic and rheumatoid arthritis cartilage. Chondrocytes from mildly degenerated osteoarthritic cartilage showed increased synthetic activity, while cells from moderately degenerated cartilage showed decreased activity. Chondrocytes from rheumatoid arthritis were found to synthesize decreased level of Type II collagen and proteoglycan molecules.These findings indicate that degeneration in osteoarthritic cartilage was initiated in the superficial zone and then gradually progressed to the mid and deep zones, While degeneration in the rheumatoid arthritic cartilage was initiated in the deep zone.
为探讨骨关节炎和类风湿关节炎患者关节软骨退变的机制,进行了免疫组织化学和生物化学研究。利用针对与人II型胶原的解绕α链和CB衍生肽特异性反应的II型胶原的溴化氰(CB)肽的多克隆抗体来鉴定关节软骨中II型胶原纤维的降解。在人骨关节炎软骨轻度变性的情况下,最突出的染色由抗CB肽抗体被发现在浅表纤维化和在interterritorial基质的浅表和中间区。相反,这些地区表现出弱染色的抗II型胶原抗体和抗蛋白多糖抗体。此外,抗纤维连接蛋白抗体和抗硫酸皮肤素蛋白聚糖抗体染色观察周围的细胞簇在浅区。另一方面,在类风湿性关节炎的情况下,关节软骨的深层被抗CB肽抗体很好地染色。II型胶原和蛋白多糖的合成也使用从骨关节炎和类风湿性关节炎软骨中获得的培养的人软骨细胞进行了研究。轻度退行性骨关节炎软骨的软骨细胞显示合成活性增加,而中度退行性软骨的细胞显示活性降低。发现类风湿关节炎软骨细胞合成Ⅱ型胶原和蛋白多糖分子的水平下降,表明骨关节炎软骨的退变始于浅层,然后逐渐向中深层发展,而类风湿关节炎软骨的退变始于深层。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
窪川経茂: "変形性関節症における関節軟骨の破壊機構に関する研究" 日本整形外科学会誌. 68. 415-425 (1994)
Tsuneshige Kubokawa:“骨关节炎中关节软骨破坏机制的研究”日本骨科学会杂志 68. 415-425 (1994)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kubokawa, Tsuneshige: "The Mechanism of articular Cartilage Degeneration in Osteoarthritis" J.Jpn.Orthop.Assoc.68. 415-424 (1994)
Kubokawa,Tsuneshige:“骨关节炎中关节软骨退化的机制”J.Jpn.Orthop.Assoc.68。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujii,K.: "The diagnostic significance of anti-TypeII collagen antibody assay in rheumatoid arthritis" Int.Orthop.16. 272-276 (1992)
Fujii,K.:“抗 II 型胶原蛋白抗体测定在类风湿性关节炎中的诊断意义”Int.Orthop.16。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJII Katsuyuki其他文献

FUJII Katsuyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUJII Katsuyuki', 18)}}的其他基金

Maximization for power transfer of wearable devices using the human body as a transmission channel
使用人体作为传输通道的可穿戴设备功率传输最大化
  • 批准号:
    26870688
  • 财政年份:
    2014
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
MRI evaluation of cruciate ligaments-bone junction in rheumatoid arthritis.
类风湿性关节炎十字韧带-骨连接处的 MRI 评估。
  • 批准号:
    13671543
  • 财政年份:
    2001
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The mechanism of joint destruction in osteoarthritis and rheumatoid arthritis.
骨关节炎和类风湿性关节炎的关节破坏机制。
  • 批准号:
    09671522
  • 财政年份:
    1997
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of anti-Type II collagen antibody formation in pathogenesis of rheumatoid arthritis.
抗 II 型胶原抗体形成在类风湿性关节炎发病机制中的作用。
  • 批准号:
    03670715
  • 财政年份:
    1991
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Clinical Application of Bone Morphogenic Protein (BMP) using Collagen Biomaterials
胶原生物材料骨形态发生蛋白(BMP)的临床应用
  • 批准号:
    62570696
  • 财政年份:
    1987
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
  • 批准号:
    MR/Y009681/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
  • 批准号:
    MR/Y022947/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Research Grant
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
  • 批准号:
    491810
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
  • 批准号:
    EP/Y027760/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Fellowship
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
  • 批准号:
    10696749
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Fibroblast-mediated inflammatory resolution of rheumatoid arthritis
成纤维细胞介导的类风湿性关节炎炎症消退
  • 批准号:
    10604629
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
  • 批准号:
    10822182
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
  • 批准号:
    10733789
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Microbial metabolites impacting the response to methotrexate in rheumatoid arthritis
微生物代谢物影响类风湿性关节炎对甲氨蝶呤的反应
  • 批准号:
    10578433
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了